The advertisement promotes NUBEQA® (darolutamide), highlighting its relevance for patients experiencing rising PSA levels while on ADT (androgen deprivation therapy).
Creative Information
| CID: | 6e67e6fd-d59f-46c2-a621-bb39d5df2a88 |
| CRID: | 82_1075-793627 |
| Domain: | nubeqa-us.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $2.93 |
| Timestamp: | 11/10/2025, 6:45:57 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/19/2025, 12:13:33 AM | 5.68s | |
| adomain_analysis | success | 11/19/2025, 2:51:05 AM | 3.88s | |
| adomain_capture | success | 11/19/2025, 2:51:01 AM | 0.12s | |
| ad_render | success | 11/19/2025, 12:13:27 AM | 27.76s | |
| brand_mapping | success | 11/18/2025, 9:31:06 PM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: Nubeqa
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1171.50 KB | ||||||||||||||||||||||
| Render Time: | 11.73 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1171.76 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


